WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Stock Ownership - Who owns Zevra Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zevra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil F. McFarlaneCEO;Pres2026-10-1220,000$11.25
$224.94kSell
Rahsaan ThompsonCLO2026-08-1442,666$11.13
$474.79kSell
Corey Michael WattonDirector2026-08-1012,300$11.25
$138.38kSell
Corey Michael WattonDirector2026-08-1012,300$4.97
$61.13kBuy
Rahsaan ThompsonChief Legal Compliance2026-06-2234,557$12.68
$438.32kSell
Rahsaan ThompsonChief Legal Compliance2026-05-111,794$11.30
$20.27kSell
John B. BodeDirector2026-03-2439,200$4.97
$194.82kBuy
John B. BodeDirector2026-03-2439,200$4.89
$191.69kBuy
Neil F. McFarlanePresident and CEO2026-02-0914,625$8.56
$125.19kSell
Timothy J. SangiovanniSVP Finance Corp Controller2026-02-033,000$9.18
$27.55kSell

1 of 2

ZVRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZVRA insiders and whales buy or sell their stock.

ZVRA Shareholders

What type of owners hold Zevra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Delaware Street Capital Master Fund LP6.88%4,095,914$49.72MInsider
Samuel J. Braun5.28%3,143,000$38.16MInsider
Christal M. M. Mickle4.52%2,690,545$32.66MInsider
Travis C. Mickle2.24%1,334,151$16.20MInsider
Matthew R. Plooster0.72%429,905$5.22MInsider
Neil F. McFarlane0.70%417,225$5.07MInsider
Danny L. Thompson0.32%190,747$2.32MInsider
R. Laduane Clifton0.24%143,515$1.74MInsider
John B. Bode0.21%123,400$1.50MInsider
Joshua Schafer0.10%62,278$756.05kInsider

1 of 3

ZVRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVRA0.08%21.68%Net SellingNet Selling
PRME0.06%63.21%
CADL0.07%22.78%Net BuyingNet Selling
AVBP0.09%20.08%Net SellingNet Buying
CGEM0.11%76.11%Net SellingNet Selling
View Top Biotech Stocks

Zevra Therapeutics Stock Ownership FAQ

Who owns Zevra Therapeutics?

Zevra Therapeutics (NASDAQ: ZVRA) is owned by 0.08% institutional shareholders, 21.68% Zevra Therapeutics insiders, and 78.24% retail investors. Delaware Street Capital Master Fund LP is the largest individual Zevra Therapeutics shareholder, owning 4.10M shares representing 6.88% of the company. Delaware Street Capital Master Fund LP's Zevra Therapeutics shares are currently valued at $48.82M.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.